The US Food and Drug Administration (FDA) is outlining a standardized approach for collecting and reporting on race and ethnicity data in clinical trials and studies in a new draft guidance document....
Some researchers are urging health systems to build the acronym SOGIE — for patients’ sexual orientation and gender identity and expression — into their data collection....
Lupus significantly and disproportionately impacts Black, Hispanic and Asian patients, but these populations are underrepresented in clinical trials for the disease....
As new treatments reach the market, a problem appears: real-world research shows dissatisfying outcomes and access disparities. One US study reveals that within the early years of a novel interventional device usage, women fare significantly worse than men, even after accounting for underlying differences....
A growing study in Wisconsin is focused on understanding Alzheimer’s disease and its impact on the African American community. ...
A recent study conducted through pediatric cancer trials found that limited health literacy and use of the Spanish language for medical communication impacted parents’ comprehension of informed consent....
A recent study published on JAMA has found that there are significant racial and ethnic disparities present within the population of women undergoing treatment for gynecologic cancer....
Lauren W. Yowelunh McLester-Davis, a University of Wisconsin–Madison neuroscientist and researcher, has joined the Native American Center for Health Professions (NACHP) in the UW School of Medicine and Public Health as its first director of Indigenous science advocacy....
They have roots in 50 countries that cover more than half of the globe’s surface. They make up more than 60% of the world’s population. They speak more than 100 different languages. Yet in medical research and public health in the United States, people with...
In recognition of National Hispanic Heritage Month The Association of Clinical Resrarch Professionals (ACRP) reached out to some cultural communications professionals to discuss the importance of clear communications between study teams and participants in clinical trials, no matter what their native languages may be....
